Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A1 | P46059 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | CTSL | P07711 | 2/20 | 0.49 |
| ▸ | CTSB | P07858 | 2/20 | 0.49 |
| ▸ | CTSS | P25774 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.47 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.47 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2779058 | 1.00 | SLC15A1 (0.53) | SLC15A1ALDH1A1CTSLCTSBCTSS | |
| SCHEMBL730695 | 1.00 | SLC15A1 (0.53) | SLC15A1ALDH1A1CTSLCTSBCTSS | |
| Hydrochloric Acid SCHEMBL7331174 | 0.98 | SLC15A1 (0.52) | SLC15A1ALDH1A1CTSLCTSBCTSS | |
| Hydrochloric Acid SCHEMBL19808961 | 0.98 | SLC15A1 (0.52) | SLC15A1ALDH1A1CTSLCTSBCTSS | |
| Hydrochloric Acid SCHEMBL7331177 | 0.98 | SLC15A1 (0.52) | SLC15A1ALDH1A1CTSLCTSBCTSS | |
| Alcohol SCHEMBL28299003 | 0.95 | SLC15A1 (0.50) | SLC15A1ALDH1A1CTSLCTSBCTSS | |
| Phenylalanine SCHEMBL10663101 | 0.89 | SLC7A5 (0.56) | SLC15A1ALDH1A1CTSLCTSBCTSS | |
| SCHEMBL27552079 | 0.88 | SLC15A1 (0.49) | SLC15A1ALDH1A1CTSLCTSBCTSS | |
| SCHEMBL6711118 | 0.88 | SLC15A1 (0.49) | SLC15A1ALDH1A1CTSLCTSBCTSS | |
| SCHEMBL31171285 | 0.87 | IARS1 (0.46) | SLC15A1KMT2AMEN1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107365368-B | Asperphenamate synthesis related protein, coding gene and application thereof | 中国科学院微生物研究所 | 2020-09-08 | — | — | CN | claimed |
| CN-107365368-A | Asperphenamate synthesis associated proteins and its encoding gene and application | 中国科学院微生物研究所 | 2017-11-21 | — | — | CN | claimed |
| CN-102250202-B | 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof | UNIV CAPITAL MEDICAL SCIENCES | 2013-08-28 | — | — | CN | claimed |
| CN-102241693-B | N,N'-di-(1-methyl-beta-carboline-3-formyl)-lysly aminoacid benzyl esters, synthetic method thereof and application thereof | UNIV CAPITAL MEDICAL SCIENCES | 2013-08-28 | — | — | CN | claimed |
| CN-102241674-B | Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester | UNIV CAPITAL MEDICAL | 2012-09-12 | — | — | CN | claimed |
| CN-101906102-B | Beta-carboline alkaloid derivative, preparation method and application thereof | UNIV CAPITAL MEDICAL | 2012-08-29 | — | — | CN | claimed |
| CN-101597322-B | 17 analogs of Tyr-Ile-Gly-Ser-Arg as well as synthetic method and application thereof in medicine | Capital Medical University (CN) | 2011-12-28 | — | — | CN | claimed |
| CN-102250202-A | 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof | UNIV CAPITAL MEDICAL | 2011-11-23 | — | — | CN | claimed |
| CN-102241674-A | Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester | UNIV CAPITAL MEDICAL | 2011-11-16 | — | — | CN | claimed |
| CN-102241693-A | N,N'-di-(1-methyl-beta-carboline-3-formyl)-lysly aminoacid benzyl esters, synthetic method thereof and application thereof | UNIV CAPITAL MEDICAL | 2011-11-16 | — | — | CN | claimed |
| CN-101497615-B | Substituted purine, preparation and use in medicine | ZHEJIANG MED XINCHANG PHARM | 2010-12-15 | — | — | CN | claimed |
| CN-101906102-A | Beta-carboline alkaloid derivative, preparation method and application thereof | UNIV CAPITAL MEDICAL | 2010-12-08 | — | — | CN | claimed |
| CN-100572382-C | The chemical sproof heterogeneous ring compound of reversing tumor cell, its preparation method and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-23 | — | — | CN | claimed |
| CN-101597290-A | β-Ka Lin-3-formyl tryptophyl amino-acid benzyl ester and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | claimed |
| CN-101597289-A | 2-tryptophyl-beta-tetrahydro carboline-3-formyol amino-acid benzyl ester and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | claimed |
| CN-101597322-A | 17 kinds of analogues of Tyr-Ile-Gly-Ser-Arg, its application synthetic and in medical science | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | claimed |
| CN-101497615-A | Substituted purine, preparation and use in medicine | XINCHANG PHARMACEUTICAL FACTORY ZHEJIANG MEDICINE CO LTD (CN) | 2009-08-05 | — | — | CN | claimed |
| CN-101239979-A | Heterocyclic compound capable of inversing tumor cell drug tolerance, preparation method and application thereof | UNIV CAPITAL MEDICAL SCIENCES (CN) | 2008-08-13 | — | — | CN | claimed |
| EP-4685150-A1 | METHOD FOR PRODUCING AMIDE GROUP-CONTAINING COMPOUND USING N-CARBOXYAMINO ACID ANHYDRIDE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2026-01-28 | — | — | EP | disclosed |
| EP-0513703-A2 | Carbamate esters of eseroline having anticholinesterase activity, a process for their preparation and relative pharmaceutical compositions containing them as the active principle | MAGIS FARMACEUTICI S.p.A. (IT) | 1992-11-19 | — | — | EP | disclosed |